近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Mahurkar, S, Moldovan, M, Suppiah, V, Sorosina, M & King, C 2016, 'Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study', The Pharmacogenomics Journal, in press. Hopkins, AM, Vitry, A I, O'Doherty, CE, Proudman, SM & Wiese, MD 2015, 'Changes to the Australian Pharmaceutical Benefit Scheme restrictions for biological disease-modifying antirheumatic drugs have influenced the use of leflunomide', International Journal of Rheumatic Diseases, v. 11, no. 1, pp. 1-3. Hopkins, AM, Wiese, MD, Proudman, SM, O'Doherty, CE, Upton, RN & Foster, DJR 2015, 'Genetic polymorphism of CYP1A2 but not total or free teriflunomide concentrations is associated with leflunomide cessation in rheumatoid arthritis', British Journal of Clinical Pharmacology, v. 81, no. 1, pp. 113-123. Hopkins, AM, King, CE, Foster, DJR, Suppiah, V, Upton, RN, Spargo, L, Cleland, L, Proudman, SM & Wiese, MD 2014, 'The rheumatoid arthritis susceptibility polymorphism PTPN22 C1858T is not associated with leflunomide response or toxicity', Journal of Clinical Pharmacy and Therapeutics, v. 39, no. 5, pp. 555-560. Hopkins, AM, O'Doherty, CE, Foster, DJR, Upton, RN, Proudman, SM & Wiese, MD 2014, 'Individualization of leflunomide dosing in rheumatoid arthritis patients', Personalized medicine, v. 11, no. 4, pp. 449-461. Main, PAE, Thomas, P, Angley, MT, Young, R, Esterman, AJ, King, CE & Fenech, M 2014, 'Lack of Evidence for Genomic Instability in Autistic children as Measured by the Cytokinesis-Block Micronucleus Cytome Assay', Autism Research: official journal of the International Society for Autism Research, online. Wiese, MD, Alotaibi, N, King, CE, Sorich, MJ, Suppiah, V, Cleland, L & Proudman, SM 2014, 'Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis', The Pharmacogenomics Journal, v. 14, pp. 350-355. Wiese, MD, Suppiah, V & King, CE 2014, 'Metabolic and safety issues for multiple sclerosis pharmacotherapy - opportunities for personalised medicine', Expert Opinion on Drug Metabolism and Toxicology, v. 10, no. 8, pp. 1145-1159. Mahurkar, S, Moldovan, M, Suppiah, V & King, CE 2013, 'Identification of Shared Genes and Pathways: A Comparative Study of Multiple Sclerosis Susceptibility, Severity and Response to Interferon Beta Treatment', PLoS One, v. 8, no. 2, article no. e57655. Mahurkar, S, Suppiah, V & King, CE 2013, 'Pharmacogenomics of interferon beta and glatiramer acetate response: A review of the literature', Autoimmunity Reviews, v. 13, pp. 178-186. Wiese, MD, Rowland, A, Polasek, T, Sorich, MJ & King, CE 2013, 'Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis', Expert Opinion on Drug Metabolism and Toxicology, v. 9, no. 8, pp. 1025-1035. Yip, TSC, King, CE, Tan, N, Dibbens, LM & Suppiah, V 2013, 'SCN1A variations and response to multiple antiepileptic drugs', The Pharmacogenomics Journal, v. 14, no. 4, pp. 385-389. King, CE, Schnabl, MJ, Spargo, L, Cleland, L, James, M, Proudman, SM & Wiese, MD 2012, 'Association of DHODH haplotype variants and response to leflunomide treatment in rheumatoid arthritis', Pharmacogenomics, v. 13, no. 12, pp. 1427-1434. Main, PAE, Angley, MT, King, CE, Thomas, P & Fenech, M 2012, 'The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: A systematic review and meta-analysis', Nutrition and Metabolism, v. 9, article no. 35. Wiese, MD, Schnabl, MJ, King, CE, Spargo, L, Sorich, MJ, Cleland, L & Proudman, SM 2012, 'Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis', Arthritis Research and Therapy, v. 14, no. 4, article no. R163. Main, PAE, Angley, MT, Thomas, P, King, CE & Fenech, M 2010, 'Folate and methionine metabolism in autism: A systematic review', American Journal of Clinical Nutrition, v. 91, no. 6, pp. 1598-1620. King, CE, Alloza, I, Rooney, M & Vandenbroeck, K 2009, 'IL7RA polymorphisms and chronic inflammatory arthropathies', Tissue Antigens: immune response genetics, v. 74, no. 5, pp. 429-431. King, CE, Favorov, A, Heggarty, S, Graham, C, Favorova, O, Ochs, M, Hawkins, S, Hutchinson, M, O'Rourke, K & Vadenbroeck, K 2009, 'Genetic polymorphisms, their allele combinations and IFN-b treatment response in Irish multiple sclerosis patients', Pharmacogenomics, v. 10, no. 7, pp. 1177-1186